For example, inactivation of the tumor suppressor P53 causes carcinogenesis by reducing apoptosis of tumor cells [12], and targeting apoptotic molecules could be developed as a treatment strategy to overcome tumor apoptotic resistance [13]. Here, TP53 is linked to neoplasm.